Clinical Trial Update: Glycoprotein IIb/IIIa Inhibitors Versus Standard Therapy in Patients with Myocardial Infarction and No-reflow [Phase 4]

View source ↗

Summary

Phase 4 trial assessing glycoprotein IIb/IIIa inhibitors versus standard therapy in acute myocardial infarction with no-reflow; the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Snippet

Sponsor: University of Luebeck | Conditions: Acute Myocardial Infarction | Phase 4 | Status: ACTIVE_NOT_RECRUITING